Shingles vaccination reaches new high

New data from the National Centre for Immunisation Research and Surveillance shows the widened availability of Shingrix has had a significant impact on jab rates The NCIRS notes that on 1 November 2023, Shingrix replaced Zostavax as the only NIP-funded vaccine for the prevention of shingles in Australia. Shingrix had become available from for purchase on